HK1121955A1 - Lotion preparation containing pyridonecarboxylic acid derivative - Google Patents

Lotion preparation containing pyridonecarboxylic acid derivative

Info

Publication number
HK1121955A1
HK1121955A1 HK09102348.6A HK09102348A HK1121955A1 HK 1121955 A1 HK1121955 A1 HK 1121955A1 HK 09102348 A HK09102348 A HK 09102348A HK 1121955 A1 HK1121955 A1 HK 1121955A1
Authority
HK
Hong Kong
Prior art keywords
acid derivative
preparation containing
pyridonecarboxylic acid
lotion preparation
containing pyridonecarboxylic
Prior art date
Application number
HK09102348.6A
Other languages
English (en)
Inventor
Tsuyoshi Hirota
Original Assignee
Maruho Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maruho Kk filed Critical Maruho Kk
Publication of HK1121955A1 publication Critical patent/HK1121955A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK09102348.6A 2005-08-01 2009-03-12 Lotion preparation containing pyridonecarboxylic acid derivative HK1121955A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005222825 2005-08-01
PCT/JP2006/315129 WO2007015453A1 (ja) 2005-08-01 2006-07-31 ピリドンカルボン酸誘導体を含有するローション剤

Publications (1)

Publication Number Publication Date
HK1121955A1 true HK1121955A1 (en) 2009-05-08

Family

ID=37708733

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09102348.6A HK1121955A1 (en) 2005-08-01 2009-03-12 Lotion preparation containing pyridonecarboxylic acid derivative

Country Status (9)

Country Link
US (1) US8778965B2 (zh)
EP (1) EP1941880B1 (zh)
JP (1) JP4393552B2 (zh)
KR (1) KR101245960B1 (zh)
CN (1) CN101272786B (zh)
CA (1) CA2615912C (zh)
ES (1) ES2553179T3 (zh)
HK (1) HK1121955A1 (zh)
WO (1) WO2007015453A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2177208A1 (en) * 2008-10-17 2010-04-21 Ferrer Internacional, S.A. Pharmaceutical topical compositions
EP2177214A1 (en) 2008-10-17 2010-04-21 Ferrer Internacional, S.A. Solid Oral Dosage Forms and Uses
EP2177209A1 (en) 2008-10-17 2010-04-21 Ferrer Internacional, S.A. Intravenous solutions and uses
TWI513688B (zh) * 2010-04-06 2015-12-21 Ferrer Int １－環丙基－８－甲基－７－〔５－甲基－６－（甲胺基）－３－吡啶基〕－４－側氧基－１，４－二氫－３－喹啉羧酸鹽
PL2556063T3 (pl) 2010-04-06 2015-12-31 Ferrer Int Sole kwasu 1-cyklopropylo-8-metylo-7-[5-metylo-6-(metyloamino)-3-pirydynylo]-4-okso-1,4-dihydro-3-chinolinokarboksylowego
CN102547215A (zh) * 2010-12-07 2012-07-04 河南省电力公司焦作供电公司 防误操作智能视觉识别系统
WO2016129657A1 (ja) * 2015-02-13 2016-08-18 マルホ株式会社 ピリドンカルボン酸系誘導体を含有する外用剤
JP7347915B2 (ja) * 2016-04-28 2023-09-20 マルホ株式会社 抗菌剤
EP3549586A1 (en) 2016-12-01 2019-10-09 Maruho Co., Ltd. Medical skin external preparation
WO2020044344A1 (en) * 2018-08-29 2020-03-05 Sol-Gel Technologies Ltd Compositions comprising ozenoxacin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4976953A (en) * 1987-03-06 1990-12-11 The Procter & Gamble Company Skin conditioning/cleansing compositions containing propoxylated glycerol derivatives
CA2114968A1 (en) * 1993-02-25 1994-08-26 John Wille Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity
US5843979A (en) * 1993-02-25 1998-12-01 Bristol-Myers Squibb Company Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity
JPH07330505A (ja) 1994-06-08 1995-12-19 Masato Suzuki 抗菌性組成物
JPH10231248A (ja) * 1997-02-19 1998-09-02 T T S Gijutsu Kenkyusho:Kk ジヒドロエトルフィン含有経皮吸収型製剤
WO1999051588A1 (fr) * 1998-04-06 1999-10-14 Toyama Chemical Co., Ltd. Derives d'acide quinolonecarboxylique ou sels de ceux-ci
JP4293755B2 (ja) * 2001-03-26 2009-07-08 富山化学工業株式会社 ピリドンカルボン酸系化合物を含有する皮膚外用剤
JP4384402B2 (ja) * 2001-11-30 2009-12-16 富山化学工業株式会社 デスフルオロピリドンカルボン酸系化合物を含有する水溶液剤およびその粉末化物並びにそれら製造方法
US20030144362A1 (en) 2002-01-28 2003-07-31 Utterberg David S. High viscosity antibacterials for cannulae
PL1731138T3 (pl) * 2004-03-31 2016-10-31 Drobnoziarnista dyspersja słabo rozpuszczalnego leku i sposób jej wytwarzania

Also Published As

Publication number Publication date
EP1941880A1 (en) 2008-07-09
CN101272786B (zh) 2011-05-04
WO2007015453A1 (ja) 2007-02-08
CA2615912C (en) 2013-10-01
US8778965B2 (en) 2014-07-15
CA2615912A1 (en) 2007-02-08
JPWO2007015453A1 (ja) 2009-02-19
EP1941880B1 (en) 2015-10-28
ES2553179T3 (es) 2015-12-04
KR101245960B1 (ko) 2013-03-21
US20100099704A1 (en) 2010-04-22
CN101272786A (zh) 2008-09-24
JP4393552B2 (ja) 2010-01-06
EP1941880A4 (en) 2010-12-29
KR20080031901A (ko) 2008-04-11

Similar Documents

Publication Publication Date Title
HK1121955A1 (en) Lotion preparation containing pyridonecarboxylic acid derivative
IL189895A0 (en) Triarylcarboxylic acid derivative
TWI366438B (en) Fungicidal composition containing acid amide derivative
GB2424581B (en) Formulations
ZA200801711B (en) Moisturizing compositions
EP1911738A4 (en) PHENOXYALKANSÄUREVERBINDUNG
GB0524962D0 (en) Topical pharmaceutical compositions
AU308121S (en) Cosmetic product
IL185399A0 (en) Pyridyl acetic acid compounds
EP1909584A4 (en) PRENYLFLAVONOID FORMULATIONS
ZA200803150B (en) Topical Formulations
HK1156311A1 (zh) 製備吡啶酸類抗菌藥物
IL187748A0 (en) Pharmaceutical compositions containing misoprostal
IL185773A0 (en) Formulations
AU308120S (en) Cosmetic product
AU308734S (en) Cosmetic product
AU308122S (en) Cosmetic product
HK1116417A1 (en) Amino acid derivatives
ZA200701243B (en) Fungicidal composition containing acid amide derivative
IL192149A0 (en) Stable s-nitrosothiol formulations
GB0504980D0 (en) Cosmetic compositions
EP1862464A4 (en) NEW CYCLIC AMINOPHENYL ALKANIC ACID DERIVATIVE
EP1895843A4 (en) MICOGEL TOPICAL FORMULAS
GB0413582D0 (en) Aqueous cosmetic compositions
PL376989A1 (pl) Preparat kosmetyczny